{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gaurav I"],"funding":["Hong Kong Innovation and Technology Commission (ITC) funding project"],"pagination":["1306"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10146377"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(8)"],"pubmed_abstract":["The citrus canker pathogen <i>Xanthomonas axonopodis</i> has caused severe damage to citrus crops worldwide, resulting in significant economic losses for the citrus industry. To address this, a green synthesis method was used to develop silver nanoparticles with the leaf extract of <i>Phyllanthus niruri</i> (GS-AgNP-LEPN). This method replaces the need for toxic reagents, as the LEPN acts as a reducing and capping agent. To further enhance their effectiveness, the GS-AgNP-LEPN were encapsulated in extracellular vesicles (EVs), nanovesicles with a diameter of approximately 30-1000 nm naturally released from different sources, including plant and mammalian cells, and found in the apoplastic fluid (APF) of leaves. When compared to a regular antibiotic (ampicillin), the delivery of APF-EV-GS-A"],"journal":["Nanomaterials (Basel, Switzerland)"],"pubmed_title":["Delivery of Apoplastic Extracellular Vesicles Encapsulating Green-Synthesized Silver Nanoparticles to Treat Citrus Canker."],"pmcid":["PMC10146377"],"funding_grant_id":["ITS/348/18FX"],"pubmed_authors":["Yang Z","Kumar G","Zhang K","Thakur S","Thakur A","Sidu RK","Iyaswamy A","Sarkar RK","Long Q","Kumar A","Gaurav I"],"additional_accession":[]},"is_claimable":false,"name":"Delivery of Apoplastic Extracellular Vesicles Encapsulating Green-Synthesized Silver Nanoparticles to Treat Citrus Canker.","description":"The citrus canker pathogen <i>Xanthomonas axonopodis</i> has caused severe damage to citrus crops worldwide, resulting in significant economic losses for the citrus industry. To address this, a green synthesis method was used to develop silver nanoparticles with the leaf extract of <i>Phyllanthus niruri</i> (GS-AgNP-LEPN). This method replaces the need for toxic reagents, as the LEPN acts as a reducing and capping agent. To further enhance their effectiveness, the GS-AgNP-LEPN were encapsulated in extracellular vesicles (EVs), nanovesicles with a diameter of approximately 30-1000 nm naturally released from different sources, including plant and mammalian cells, and found in the apoplastic fluid (APF) of leaves. When compared to a regular antibiotic (ampicillin), the delivery of APF-EV-GS-A","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2026-04-08T14:23:24.741Z","creation":"2025-02-19T02:24:02.033Z"},"accession":"S-EPMC10146377","cross_references":{"pubmed":["37110891"],"doi":["10.3390/nano13081306"]}}